We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
[Pharmacotherapy of osteoporosis accompanied by lifestyle-related diseases].
Clinical Calcium 2011 May
Lifestyle-related diseases, such as diabetes mellitus, hypertension and dyslipidemias, are often accompanied by osteoporosis. Treatment of osteoporosis in such cases is essentially the same as that for primary osteoporosis, but it is important to be aware of the interference between osteoporosis treatment and the drugs used for the lifestyle-related diseases. Raloxifene, bisphosphonates and activated vitamin D are commonly used for treatment of osteoporosis, and they are reported to have a positive effect on atherosclerosis. Beta-blocker use, particularly selective beta-blocker, is associated with reduced fracture risk. Statin is also reported to stimulate bone formation via bone morphogenetic protein-2 expression, but their clinical utility has not yet been confirmed. One class of antidiabetic drugs, thiazolidinediones, causes bone loss and further increases fracture risk, placing thiazolidinediones in the category of drugs causing secondary osteoporosis.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app